ID: ALA556232

Max Phase: Preclinical

Molecular Formula: C20H31N3O3S

Molecular Weight: 393.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCn1ccc2c(C)c(NS(C)(=O)=O)c(C)c(NC(=O)C(C)(C)C)c21

Standard InChI:  InChI=1S/C20H31N3O3S/c1-8-9-11-23-12-10-15-13(2)16(22-27(7,25)26)14(3)17(18(15)23)21-19(24)20(4,5)6/h10,12,22H,8-9,11H2,1-7H3,(H,21,24)

Standard InChI Key:  HEQUJUFHPZYAJI-UHFFFAOYSA-N

Associated Targets(Human)

THP-1 11052 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acyl-CoA:cholesterol acyltransferase 1121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 393.55Molecular Weight (Monoisotopic): 393.2086AlogP: 4.41#Rotatable Bonds: 6
Polar Surface Area: 80.20Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.43CX Basic pKa: CX LogP: 4.06CX LogD: 4.05
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -1.04

References

1. Shoji Y, Takahashi K, Ohta M, Kasai M, Kunishiro K, Kanda M, Yogai S, Takeuchi Y, Shirahase H..  (2009)  Novel indoline-based acyl-CoA: cholesterol acyltransferase inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities.,  17  (16): [PMID:19608421] [10.1016/j.bmc.2009.06.047]

Source